1.Advances and current status of research on stroke and exosomes: A visual analysis
Journal of Apoplexy and Nervous Diseases 2025;42(9):810-822
Objective To investigate the research hotspots, development trends, and potential challenges in the field of stroke and exosomes based on bibliometric and visual analyses, and to provide scientific evidence for basic research and clinical translation. Methods The Web of Science database was used to obtain related articles published up to 2024, and CiteSpace and other tools were used to perform visual analyses from various aspects such as publication trends, collaboration networks, co-occurrence and clustering of keywords, and literature burst analysis. Results A total of 1 153 articles were included. The analysis showed an overall increasing trend in the number of publications per year. The institution with the highest number of publications was Henry Ford Health System, the author with the highest number of publications was Professor Chopp, and the journal with the highest number of articles Int J Mol Sci. High-frequency keywords included "extracellular vesicles" "ischemic stroke" and "stroke", forming 12 research clusters, with neural repair and barrier protection as the key research directions. Conclusion The research on stroke and exosomes has been increasing year by year, with rapid development in recent years and the formation of an interdisciplinary pattern. Future studies should focus on the molecular mechanisms mediated by exosomes and their clinical application in stroke treatment, so as to promote the development of precision medicine and provide new therapeutic approaches.
Stroke
;
Exosomes
;
Bibliometrics
2.The ubiquitin-proteasome system: A potential target for the MASLD.
Yue LIU ; Meijia QIAN ; Yonghao LI ; Xin DONG ; Yulian WU ; Tao YUAN ; Jian MA ; Bo YANG ; Hong ZHU ; Qiaojun HE
Acta Pharmaceutica Sinica B 2025;15(3):1268-1280
Metabolic dysfunction-associated steatotic liver disease (MASLD), the most prevalent chronic liver condition globally, lacks adequate and effective therapeutic remedies in clinical practice. Recent studies have increasingly highlighted the close connection between the ubiquitin-proteasome system (UPS) and the progression of MASLD. This relationship is crucial for understanding the disease's underlying mechanism. As a sophisticated process, the UPS govern protein stability and function, maintaining protein homeostasis, thus influencing a multitude of elements and biological events of eukaryotic cells. It comprises four enzyme families, namely, ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes (E2), ubiquitin-protein ligases (E3), and deubiquitinating enzymes (DUBs). This review aims to delve into the array of pathways and therapeutic targets implicated in the ubiquitination within the pathogenesis of MASLD. Therefore, this review unveils the role of ubiquitination in MASLD while spotlighting potential therapeutic targets within the context of this disease.
3.Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function.
Yuheng JIN ; Xuxin QI ; Xiaoli YU ; Xirui CHENG ; Boya CHEN ; Mingfei WU ; Jingyu ZHANG ; Hao YIN ; Yang LU ; Yihui ZHOU ; Ao PANG ; Yushen LIN ; Li JIANG ; Qiuqiu SHI ; Shuangshuang GENG ; Yubo ZHOU ; Xiaojun YAO ; Linjie LI ; Haiting DUAN ; Jinxin CHE ; Ji CAO ; Qiaojun HE ; Xiaowu DONG
Acta Pharmaceutica Sinica B 2025;15(3):1659-1679
HDAC7, a member of class IIa HDACs, plays a pivotal regulatory role in tumor, immune, fibrosis, and angiogenesis, rendering it a potential therapeutic target. Nevertheless, due to the high similarity in the enzyme active sites of class IIa HDACs, inhibitors encounter challenges in discerning differences among them. Furthermore, the substitution of key residue in the active pocket of class IIa HDACs renders them pseudo-enzymes, leading to a limited impact of enzymatic inhibitors on their function. In this study, proteolysis targeting chimera (PROTAC) technology was employed to develop HDAC7 drugs. We developed an exceedingly selective HDAC7 PROTAC degrader B14 which showcased superior inhibitory effects on cell proliferation compared to TMP269 in various diffuse large B cell lymphoma (DLBCL) and acute myeloid leukemia (AML) cells. Subsequent investigations unveiled that B14 disrupts BCL6 forming a transcriptional inhibition complex by degrading HDAC7, thereby exerting proliferative inhibition in DLBCL. Our study broadened the understanding of the non-enzymatic functions of HDAC7 and underscored the importance of HDAC7 in the treatment of hematologic malignancies, particularly in DLBCL and AML.
4.Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis.
Wenxiang HONG ; Hongbo MA ; Zhaoxu YANG ; Jiaying WANG ; Bowen PENG ; Longling WANG ; Yiwen DU ; Lijun YANG ; Lijiang ZHANG ; Zhibin LI ; Han HUANG ; Difeng ZHU ; Bo YANG ; Qiaojun HE ; Jiajia WANG ; Qinjie WENG
Acta Pharmaceutica Sinica B 2025;15(3):1626-1642
Dendritic cells (DCs) serve as the primary antigen-presenting cells in autoimmune diseases, like rheumatoid arthritis (RA), and exhibit distinct signaling profiles due to antigenic diversity. Type II collagen (CII) has been recognized as an RA-specific antigen; however, little is known about CII-stimulated DCs, limiting the development of RA-specific therapeutic interventions. In this study, we show that CII-stimulated DCs display a preferential gene expression profile associated with migration, offering a new perspective for targeting DC migration in RA treatment. Then, saikosaponin D (SSD) was identified as a compound capable of blocking CII-induced DC migration and effectively ameliorating arthritis. Optineurin (OPTN) is further revealed as a potential SSD target, with Optn deletion impairing CII-pulsed DC migration without affecting maturation. Function analyses uncover that OPTN prevents the proteasomal transport and ubiquitin-dependent degradation of C-C chemokine receptor 7 (CCR7), a pivotal chemokine receptor in DC migration. Optn-deficient DCs exhibit reduced CCR7 expression, leading to slower migration in CII-surrounded environment, thus alleviating arthritis progression. Our findings underscore the significance of antigen-specific DC activation in RA and suggest OPTN is a crucial regulator of CII-specific DC migration. OPTN emerges as a promising drug target for RA, potentially offering significant value for the therapeutic management of RA.
5.Research on the mechanism of action of temporary party organizations in public health emergencies:a case study of Guangdong medical teams'success in pandemic response
Guangjian WANG ; Qiaojun LI ; Zongfeng WANG
Modern Hospital 2024;24(10):1495-1499,1507
In public health emergencies,medical emergency response efforts face governance challenges such as complex and variable tasks,difficulties in team organization,and uncertain working areas.The establishment of temporary party organiza-tions plays a crucial role in efficiently achieving the goals of medical emergency teams and stabilizing social order.This paper an-alyzes the functional positioning,key tasks,and operational mechanisms of temporary party organizations within Guangdong's medical teams aiding in the pandemic response.The study finds that these temporary party organizations effectively address the complex challenges of public health emergencies through functions such as strengthening political leadership,mobilizing public support,coordinating organization,and serving the community.This provides important insights for advancing the construction of governance systems for public health emergencies in China.
6.Monitoring results of rodents in Hainan Province in 2022 and the relationship between rodent density and meteorological factors in Haikou
ZENG Xuexia ; LI Qiaojun ; LI Puyu
China Tropical Medicine 2024;24(5):532-
Abstract: Objective By analyzing the monitoring results of rodents in Hainan Province in 2022, the species composition, distribution, seasonal fluctuation, and density of rodents were understood and mastered, and the correlation between rodent density and meteorological factors in Haikou was explored, so as to provide a scientific basis for vector control and prevention and control of rodent-borne infectious diseases. Methods Using the night cage method, according to the "2022 Hainan Province Rodent Monitoring Implementation Plan”, monitoring was conducted in 17 cities and counties every two months starting from January. Excel 2021 software was used to sort out the monitoring data and draw the chart, and SPSS 26.0 was used for statistical analysis. Spearman correlation analysis was used for the correlation between rodent density and meteorological factors. Results In 2022, the overall rodent density in Hainan Province was 4.32% (1 166/27 008). Brown rat (Rattus norvegicus) was the dominant species, accounting for 72.21% (842/1 166) of the total captures. In terms of area, the highest rodent density was 27.27% (367/1 346) in Changjiang County, followed by Haikou, Wanning, and Sanya, with rodent densities of 8.59% (155/1 804), 6.55% (77/1 176), and 5.11% (81/1 586), respectively. Different habitat types had different rodent densities, with the highest in rural residential areas at 4.49% (402/8 962); key industries (dining, food manufacturing and sales, construction sites, slaughtering, brewing, etc.) had a density of 4.41% (404/9 153); and urban residential areas had a density of 4.05% (360/8 893). In terms of seasonal fluctuation, the overall rodent density showed a downward trend after reaching its peak in May. The peak rodent density in rural residential areas was in July (5.73%), there was no distinct peak period in urban residential areas, and the peak period for key industries occurred in May (6.87%). Spearman correlation analysis showed that the rodent density in Haikou was positively correlated with average temperature and accumulated sunshine time (r=0.90, 0.9; P<0.05). Conclusions The density of rodents in Hainan Island is relatively high. Cities and counties need to compare annual monitoring data to reasonably assess the risk and formulate appropriate control measures according to the actual local situation.
7.Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
Wang MENGXIN ; Vulcano STEPHEN ; Xu CHANGLU ; Xie RENJIAN ; Peng WEIJIE ; Wang JIE ; Liu QIAOJUN ; Jia LEE ; Li ZHI ; Li YUMEI
Journal of Pharmaceutical Analysis 2024;14(3):308-320
Ribosomopathies encompass a spectrum of disorders arising from impaired ribosome biogenesis and reduced functionality.Mutation or dysexpression of the genes that disturb any finely regulated steps of ribosome biogenesis can result in different types of ribosomopathies in clinic,collectively known as ribosomopathy genes.Emerging data suggest that ribosomopathy patients exhibit a significantly heightened susceptibility to cancer.Abnormal ribosome biogenesis and dysregulation of some ribo-somopathy genes have also been found to be intimately associated with cancer development.The cor-relation between ribosome biogenesis or ribosomopathy and the development of malignancies has been well established.This work aims to review the recent advances in the research of ribosomopathy genes among human cancers and meanwhile,to excavate the potential role of these genes,which have not or rarely been reported in cancer,in the disease development across cancers.We plan to establish a theoretical framework between the ribosomopathy gene and cancer development,to further facilitate the potential of these genes as diagnostic biomarker as well as pharmaceutical targets for cancer treatment.
8.Recommendations on rehabilitation treatment of different populations infected with novel coronavirus during the recovery period
Xiaohui LEI ; Yanping HUI ; Ni ZHANG ; Yaofeng LI ; Zhongheng WU ; Hongfei QIAO ; Qiaojun ZHANG ; Haifeng YUAN
Journal of Xi'an Jiaotong University(Medical Sciences) 2023;44(6):969-971
Patients with novel coronavirus infection still have many functional disorders during the recovery period. The timely intervention of rehabilitation treatment has important clinical significance in improving the patients’ functions and their ability of daily living. Based on the current evidence of evidence-based medicine and clinical practice, this paper summarizes the rehabilitation treatment and precautions of patients with simple novel coronavirus infection and different groups with previous dysfunction and novel coronavirus infection (such as neurological dysfunction, chronic pain, and bone and joint diseases) with a view to providing clinical reference for the rehabilitation treatment of patients with novel coronavirus infection during the recovery period.
9.Deubiquitination complex platform: A plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes.
Yi-Zheng FANG ; Li JIANG ; Qiaojun HE ; Ji CAO ; Bo YANG
Acta Pharmaceutica Sinica B 2023;13(7):2955-2962
Deubiquitinating enzymes (DUBs) or deubiquitinases facilitate the escape of multiple proteins from ubiquitin‒proteasome degradation and are critical for regulating protein expression levels in vivo. Therefore, dissecting the underlying mechanism of DUB recognition is needed to advance the development of drugs related to DUB signaling pathways. To data, extensive studies on the ubiquitin chain specificity of DUBs have been reported, but substrate protein recognition is still not clearly understood. As a breakthrough, the scaffolding role may be significant to substrate protein selectivity. From this perspective, we systematically characterized the scaffolding proteins and complexes contributing to DUB substrate selectivity. Furthermore, we proposed a deubiquitination complex platform (DCP) as a potentially generic mechanism for DUB substrate recognition based on known examples, which might fill the gaps in the understanding of DUB substrate specificity.
10.Clinical characteristics of acute ischemic stroke patients complicated with obstructive sleep apnea hypopnea syndrome
Huaman WU ; Guoqiang SONG ; Jie LI ; Juan XU ; Sijie CAI ; Jing WANG ; Qiaojun WANG ; Fei HAN ; Rui CHEN
Chinese Journal of Health Management 2021;15(2):122-128
Objective:To analyze the clinical characteristics of patients suffering from acute ischemic stroke (AIS) complicated with obstructive sleep apnea-hypopnea syndrome (OSAHS).Methods:Data of patients with AIS who visited the Second Affiliated Hospital of Soochow University from January 2015 to June 2020 and underwent polysomnography monitoring (PSG) in the sleep center were collected retrospectively. Patients were divided into OSAHS group and AIS only group. Demographic information of patients, general clinical data, hematological indicators of glucose and lipid metabolism and inflammatory markers, PSG parameters and neurological function scores were collected, including the National Institutes of Health Stroke Scale (NIHSS) on admission and the modified Rankin Scale (mRS) on discharge. We compared the differences between the two groups. In addition, OSAHS group were divided into good prognosis and poor prognosis subgroups according to mRS score. The differences between the two subgroups were compared.Results:A total of 112 AIS patients combined with OSAHS and 89 AIS only patients were included. The proportion of non-rapid eye movement stages 1+2 [(N1+N2) %], arousal index, the oxygen desaturation index (ODI), percentage of total sleep time with oxygen saturation<90% (TS90) in the OSAHS group were higher than those in the AIS only group, while N3%, lowest nocturnal oxygen saturation (LSaO 2) were lower (all P<0.05). There was no statistical difference in the distribution of cerebral apoplexy lesions (cortex, subcortical, brainstem, cerebellum) between the two groups, but the proportion of patients with multifocal cerebral apoplexy in the OSAHS group was higher ( P=0.032). There was no statistical difference in NIHSS score on admission between the two groups, but the neutrophil/lymphocyte ratio (NLR) score ( P=0.004) and mRS score on discharge ( P=0.010) of the OSAHS group were significantly higher than those in the AIS only group. There were 74 patients in the good prognosis group and 38 in the poor prognosis group. The analysis showed that the NIHSS and NLR scores of the poor prognosis group were higher than the good prognosis group, admission NIHSS score was a risk factor for poor prognosis, all P<0.01. Conclusions:AIS patients complicated with OSAHS are characterized by disordered sleep structure, more severe nocturnal hypoxia, higher risk of developing multiple lesions, poor neurological function recovery at discharge, and high inflammatory index of NLR. Among them, patients with poor prognosis have poorer sleep efficiency, and high admission NIHSS score is a risk factor for poor prognosis.

Result Analysis
Print
Save
E-mail